Provided by Tiger Trade Technology Pte. Ltd.

UNI-BIO GROUP

0.114
-0.007-5.79%
Volume:3.84M
Turnover:444.54K
Market Cap:680.69M
PE:8.46
High:0.118
Open:0.118
Low:0.114
Close:0.121
52wk High:0.168
52wk Low:0.049
Shares:5.97B
HK Float Shares:5.97B
Volume Ratio:0.66
T/O Rate:0.06%
Dividend:0.00
Dividend Rate:2.43%
EPS(LYR):0.013
ROE:26.27%
ROA:13.12%
PB:1.78
PE(LYR):8.46
PS:1.15

Loading ...

3 Asian Penny Stocks With Market Caps Up To US$500M

Simply Wall St.
·
Dec 11

Uni-Bio Science (00690) Publishes November 2025 Monthly Return

Bulletin Express
·
Dec 03

Uni-Bio Science Group Ltd. Announces New Strategic Focus on Regenerative Medicine, Expands Global Collaboration, and Advances Pipeline in Muscular-Skeletal, Skin, Ocular, and ENT Regeneration

Reuters
·
Nov 24

Uni-Bio Science Group Embarks on New Strategy and Launches New Website, Advancing Towards Becoming a Global Leader in Regenerative Medicine

THOMSON REUTERS
·
Nov 24

Uni-Bio Science Group (00690) Publishes Monthly Return for 31 October 2025

Bulletin Express
·
Nov 03

UNI-BIO GROUP (00690) Shareholders Deposit Shares Worth HK$113 Million into HSBC

Stock News
·
Sep 24

Uni-Bio Science Partners Kexing Biopharm to Commercialize Bogutai in Six Markets; Shares Rise 7%

MT Newswires Live
·
Sep 15

BRIEF-Uni-Bio Science's Unit Expands Global Reach Of Bogutai Through Strategic Partnership

Reuters
·
Sep 12

Uni-Bio Science Group and Kexing Biopharm Form Strategic Alliance to Globalize Osteoporosis Treatment Bogutai®

Reuters
·
Sep 12

Uni-Bio Science Group and Kexing Biopharm Forge Strategic Partnership to Accelerate Global Expansion of Osteoporosis Treatment Bogutai®

THOMSON REUTERS
·
Sep 12

UNI-BIO GROUP (00690): Signs Strategic Cooperation Agreement with Kexing Biopharm to Expand Global Market for Bogutai®

Stock News
·
Sep 12

Uni-Bio Science Group Ltd - Unit Expands Global Reach of Bogutai Through Strategic Partnership

THOMSON REUTERS
·
Sep 12

Uni-Bio Science - Unit Enters Strategic Cooperation With Kexing Biopharm

THOMSON REUTERS
·
Sep 12

Uni-Bio Science Group Announces 2025 Interim Results

THOMSON REUTERS
·
Aug 28

UNI-BIO GROUP (00690) Reports Interim Results with Net Profit of HK$75.955 Million, Up 12.7% Year-over-Year

Stock News
·
Aug 28

Uni-Bio Science Group H1 Revenue HKD 310.2 Million

THOMSON REUTERS
·
Aug 28

Uni-Bio Science Group H1 Gross Margin 81.9%

THOMSON REUTERS
·
Aug 28

Uni-Bio Science Extends Maturity on 4 Loans; Shares Gain 2%

MT Newswires Live
·
Jul 29

Uni-Bio Science's Antifungal Drug Marketing Application Gets Accepted by Chinese Regulator

MT Newswires Live
·
Jul 18

Uni-Bio Science Group Ltd. Secures NMPA Acceptance for Isavuconazonium Sulfate Capsules, Paving Way for 2026 Launch

Reuters
·
Jul 18